Harvey Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-150,751
Closed -$3.6M 88
2019
Q4
$3.6M Sell
150,751
-1,800
-1% -$43K 1.6% 21
2019
Q3
$4.09M Sell
152,551
-1,800
-1% -$48.3K 2.03% 20
2019
Q2
$4.19M Sell
154,351
-4,821
-3% -$131K 2.01% 21
2019
Q1
$5.52M Sell
159,172
-5,500
-3% -$191K 2.65% 13
2018
Q4
$3.21M Sell
164,672
-20,000
-11% -$390K 1.71% 21
2018
Q3
$4.92M Buy
184,672
+27,192
+17% +$724K 1.96% 19
2018
Q2
$5.95M Sell
157,480
-1,100
-0.7% -$41.5K 2.36% 14
2018
Q1
$5.18M Buy
158,580
+3,000
+2% +$98K 1.94% 22
2017
Q4
$7.57M Buy
155,580
+11,850
+8% +$577K 2.74% 11
2017
Q3
$7.77M Sell
143,730
-2,025
-1% -$109K 3.13% 12
2017
Q2
$8.19M Sell
145,755
-48,625
-25% -$2.73M 3.51% 8
2017
Q1
$7.62M Sell
194,380
-37,850
-16% -$1.48M 3.42% 10
2016
Q4
$5.21M Buy
232,230
+48,100
+26% +$1.08M 2.43% 17
2016
Q3
$4.18M Sell
184,130
-22,400
-11% -$509K 1.29% 18
2016
Q2
$4.87M Buy
206,530
+54,850
+36% +$1.29M 2.44% 15
2016
Q1
$3.09M Sell
151,680
-5,500
-3% -$112K 1.5% 23
2015
Q4
$8.09M Sell
157,180
-750
-0.5% -$38.6K 3.19% 10
2015
Q3
$6.73M Buy
157,930
+2,900
+2% +$124K 2.69% 13
2015
Q2
$7.11M Buy
155,030
+5,350
+4% +$245K 2.41% 15
2015
Q1
$5.68M Buy
149,680
+13,050
+10% +$495K 2.09% 16
2014
Q4
$3.87M Buy
136,630
+29,600
+28% +$838K 1.48% 22
2014
Q3
$2.71M Hold
107,030
1.06% 30
2014
Q2
$3.12M Buy
107,030
+100
+0.1% +$2.92K 1.12% 27
2014
Q1
$2.77M Buy
106,930
+63,530
+146% +$1.65M 1.1% 27
2013
Q4
$1.12M Buy
+43,400
New +$1.12M 0.46% 43